STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION
Pharmacological therapy remains the primary approach to atrial fibrillation (AF). Management of all AF patients includes the decision on rate or rhythm control. The latter means antiarrhythmic drugs application that are being selected primarily by safety reasons and depend on individual characterist...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2017-08-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1664 |
| _version_ | 1797856917702311936 |
|---|---|
| author | S. G. Kanorsky Yu. S. Kovalenko |
| author_facet | S. G. Kanorsky Yu. S. Kovalenko |
| author_sort | S. G. Kanorsky |
| collection | DOAJ |
| description | Pharmacological therapy remains the primary approach to atrial fibrillation (AF). Management of all AF patients includes the decision on rate or rhythm control. The latter means antiarrhythmic drugs application that are being selected primarily by safety reasons and depend on individual characteristics of patients. The article presents a brief description of efficacy and safety of antiarrhythmics themselves and other drugs for sinus rhythm control in AF. Novel data shows possibility to decrease stroke risk and mortality, and to cease anticoagulation in more thorough sinus rhythm retention. |
| first_indexed | 2024-04-09T20:48:20Z |
| format | Article |
| id | doaj.art-eec60f5f96e24329b79d92af4268ba17 |
| institution | Directory Open Access Journal |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| last_indexed | 2024-04-09T20:48:20Z |
| publishDate | 2017-08-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj.art-eec60f5f96e24329b79d92af4268ba172023-03-29T21:23:28Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202017-08-010717117710.15829/1560-4071-2017-7-171-1771440STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATIONS. G. Kanorsky0Yu. S. Kovalenko1Kubansky State Medical University of the Ministry of HealthKubansky State Medical University of the Ministry of HealthPharmacological therapy remains the primary approach to atrial fibrillation (AF). Management of all AF patients includes the decision on rate or rhythm control. The latter means antiarrhythmic drugs application that are being selected primarily by safety reasons and depend on individual characteristics of patients. The article presents a brief description of efficacy and safety of antiarrhythmics themselves and other drugs for sinus rhythm control in AF. Novel data shows possibility to decrease stroke risk and mortality, and to cease anticoagulation in more thorough sinus rhythm retention.https://russjcardiol.elpub.ru/jour/article/view/1664atrial fibrillationantiarrhythmic drugsrate controlrhythm control |
| spellingShingle | S. G. Kanorsky Yu. S. Kovalenko STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION Российский кардиологический журнал atrial fibrillation antiarrhythmic drugs rate control rhythm control |
| title | STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION |
| title_full | STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION |
| title_fullStr | STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION |
| title_full_unstemmed | STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION |
| title_short | STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION |
| title_sort | state of the art pharmacological therapy for atrial fibrillation |
| topic | atrial fibrillation antiarrhythmic drugs rate control rhythm control |
| url | https://russjcardiol.elpub.ru/jour/article/view/1664 |
| work_keys_str_mv | AT sgkanorsky stateoftheartpharmacologicaltherapyforatrialfibrillation AT yuskovalenko stateoftheartpharmacologicaltherapyforatrialfibrillation |